- Cognitive Endpoints in Huntington's Disease Trials: A Conceptual Framework for Clinical Meaningfulness
- Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets
- Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's disease
- Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models
- Mapping iron content and white matter integrity in the anterior thalamic radiations across Huntington's disease stages
- Rho kinase isoforms in neurodegeneration: from cellular functions to therapeutic targets
- Investigating Curvature Sensing by the Nt17 Domain of Huntingtin Protein
- Understanding the relationship between patient-reported outcome measures, clinician-rated assessments, and performance-based measures (cognitive tests and device-based estimates) of symptoms and functioning in people with Huntington's disease
- Metformin decreases RAN proteins, rescues splicing abnormalities and improves behavioral phenotypes in SCA8 BAC mice
- Role of Calmodulin in Neurodegeneration and Neuroprotection
- The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease
- DNA Methylation Status of Regulatory Regions of Apoptosis-Associated Genes in Dystropy "Huntington's Disease-Non-Small Cell Lung Cancer"
- Morin hydrate: a comprehensive review on therapeutic potential in treating neurological diseases
- The Role of the human microbiome in neurodegenerative diseases: A Perspective
- Expression of polyglutamine repeats at the pathogenic threshold modestly enhances tau neurotoxicity and protein accumulation in <em>C. elegans</em>
- SpatialFinder: A Human-in-the-Loop Vision-Language Framework for Prioritizing High-Value Regions in Spatial Transcriptomics
- Post-translational modifications of huntingtin's N17 region: implications for self-association and membrane binding
- Speech profile in patients with Huntington's Disease: cognitive, clinical, and sociodemographic correlations
- Novel Thieno[3,2-b]Pyridine Derivatives in the Treatment of Huntington's Disease
- Localization and connections of the tail of caudate and caudal putamen in mouse brain
- Novel Compounds for Treating Huntington's Disease
- The Hsp40 co-chaperone DNAJC7 modifies polyglutamine but not polyglycine aggregation
- White matter microstructure changes across the lifespan: a meta-analysis of longitudinal diffusion MRI studies
- White Matter Tract Vulnerability to Amyloid Pathology on the Alzheimer's Disease Continuum
- <em>cnnm-5</em> knockdown improves proteostasis of mutant Huntingtin protein in <em>C. elegans</em>
- Abnormal neurodevelopment predisposes to cortical hyperexcitability in Huntington's disease
- Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders
- Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice
- Application of zebrafish (Danio rerio) as a model organism for central nervous system disorders screening of natural products
- Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?
- Upper Extremity Motor Performance During a Shirt Buttoning Task in Huntington's Disease
- Psychosis in Huntington's disease: a review and comparison with schizophrenia
- Neuroprotective mechanism of LincRNA in neurodegenerative diseases
- Striatal neuron excitability is regulated by huntingtin in the adult brain
- Selective striatal pathological changes in a novel human HTT exon 1 knock-in mouse model of Huntington's disease
- cGAS-STING axis: A central regulator of neural homeostasis and neuroinflammatory pathogenesis
- Natural Neuroinflammatory Modulators: Therapeutic Potential of Fungi-Derived Compounds in Selected Neurodegenerative Diseases
- Amelioration of behavioral and neural deficits in animal models of neurodegenerative disease by nanoformulations of curcumin and quercetin
- Fatty Acid Profile in the Liver of Mice with Early- and Late-Onset Forms of Huntington's Disease
- Metallothionein and neurodegenerative diseases
- Small Extracellular Vesicles in Neurodegenerative Disease: Emerging Roles in Pathogenesis, Biomarker Discovery, and Therapy
- Human Glucose Transporters in Health and Selected Neurodegenerative Diseases
- Prebiotics improve motor function, cognition and gut health in a preclinical model of Huntington's disease
- Target sequence-conditioned design of peptide binders using masked language modeling
- Bias in HD-ISS staging introduced by the FreeSurfer cross-sectional stream: Insights from the Huntington's Disease Young Adult Study (HD-YAS)
- Targeting IDO1 in Huntington's Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica
- Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington's Disease Progression
- Emerging drivers of DNA repeat expansions
- Bridging Huntington's disease research with big data science: Harmonized neuroimaging datasets from multiple studies
- The interplay between physical exercise and autophagy signaling in brain health, neurodegenerative diseases and aging
- Primary cortical neurons form calcium-phosphate sheets with a bone-precursor-like ultrastructure
- Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis
- Population Pharmacokinetic and Exposure-Efficacy Analyses of Valbenazine in Patients with Huntington's Disease: Supporting Dose Selection for Chorea Management
- Transplanted human striatal progenitors exhibit functional integration and modulate host circuitry in a Huntington's disease animal model
- Prevalence and predictors of medical information avoidance: a systematic review and meta-analysis
- Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion
- Efficacy and safety of cholinesterase inhibitors and memantine for cognitive symptoms in patients with Huntington's disease: A systematic review
- Early onset obsessive-compulsive disorder in a patient with Huntington's disease - A case report
- Vesicular monoamine transport inhibitors: current uses and future directions
- USP7 deubiquitinase stabilizes FAN1 to support DNA crosslink repair and suppress CAG repeat expansion
- Localization of Mutant Huntingtin with HTT Exon1 P90 C-terminal Neoepitope Antibodies in Relation to Regional and Neuronal Vulnerability in Forebrain in Q175 Mice and Human Huntington's Disease
- Examination of speech processing in noise reveals cognitive deficits in early Huntington's disease
- NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies
- Longitudinal Investigation of Structural and Resting-State Effective Connectivity Alterations in a Non-Human Primate Model of Huntington's Disease
- Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington's disease
- Neuron-derived extracellular vesicles in plasma present a potential non-invasive biomarker for Huntingtin protein and RNA assessment in Huntington disease
- Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled study
- Special issue: Glia and non-neuronal cells in Huntington's disease
- The role of oligodendroglial dysfunction in Huntington's disease
- Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients
- Neuroinflammation in Huntington's disease: Causes, consequences, and treatment strategies
- The role of astrocytes in human Huntington's disease pathology
- Dysphagia in Huntington's Disease: An Evaluation of Swallowing Disturbance across the HD-ISS Staging Spectrum
- Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington's disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption
- Cyrene: A Novel Geroprotective Compound that Extends Lifespan and Healthspan in C. elegans and Drosophila
- Is the renin-angiotensin system a friend or foe in neurological diseases? Unveiling its role and therapeutic potential
- High-Affinity, Structure-Validated and Selective Macrocyclic Peptide Tools for Chemical Biology Studies of Huntingtin
- Nanomaterials engineered for photothermal therapy in neural tumors and neurodegenerative diseases: biomaterial design, clinical mechanisms and applications
- Antidepressant Treatment in Huntington's Disease: Regional and Case-Control Variation
- Identification of Key Lactylation-Related Genes and Their Relevance to the Connection Between Parkinson's Disease and the Immune System Through Integrated Bioinformatics Analysis
- Astrocyte heterogeneity and gliosis in Huntington's disease: Histopathological insights into striatal and white matter pathology
- The Beneficial Effects of Berberine on Brain Functions in Age-Related Neurological Disorders: From Molecular Signaling to Treatment
- Fast-track to a Huntington disease diagnosis - I saw the "boxcar" sign
- Oxidative Stress in DNA Damage and Neurodegenerative Diseases: Unveiling The Mechanisms and Therapeutic Opportunities
- Neuroprotective and gut health benefits of Ugni molinae in preclinical Huntington's disease models
- Research progress on platelet factor 4 in improving cognition
- A Coarse-Grained MD Model for Disorder-To-Order Transitions in PolyQ Aggregation
- Huntington Disease and Chorea
- Huntingtin reduction results in altered nuclear structure and heterochromatic instability
- Insights into Caspase-6 Mutations and Neuropathology in Huntington's Disease and Psychiatric Disorders: A Structural Genomics and Drug Repurposing Approach
- Along-Tract Diffusion Alterations in the Dentato-Rubro-Thalamic Tract Correlate With Motor and Cognitive Decline in Huntington's Disease
- Natural Bioactive Compounds as Modulators of Autophagy: A Herbal Approach to the Management of Neurodegenerative Diseases
- The DNA replication checkpoint targets the kinetochore to reposition DNA structure-induced replication damage to the nuclear periphery
- Coniferaldehyde reverses 3-nitropropionic acid-induced Huntington's disease pathologies via PKM2 restoration and JAK2/STAT3 inhibition
- Nanotechnological Approaches for Mitochondrial Targeting in Neurodegenerative Diseases
- Intermittent Fasting as a Neuroprotective Strategy: Gut-Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders
- Development of the Movement Disorders Interpretation Bias Scale and psychometric evaluation in adults with Huntington's disease
- Anti-Inflammatory Effects of Cannabinoids in Therapy of Neurodegenerative Disorders and Inflammatory Diseases of the CNS
- The ethics and economics of organoid commercialization: potential donors' perspectives
- Neural Correlates of Huntington's Disease Based on Electroencephalography (EEG): A Mechanistic Review and Discussion of Excitation and Inhibition (E/I) Imbalance
